Access to innovative cancer medicines in a middle-income country - the case of Mexico

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, October 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#50 of 465)
High Attention Score compared to outputs of the same age (86th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

So far, Altmetric has seen 13 X posts from 9 X users, with an upper bound of 9,230 followers.

@VernovaN @jorroser @lopezobrador_ El amar las tinieblas, es tema tuyo. Pero decir la verdad no es "vomitar odio". https://t.co/C0h96TAMxd https://t.co/WDoD5ziafa

RT @editorjoppp: Access to innovative cancer medicines in a middle-income country - the case of Mexico https://t.co/PUDS52j0oY

RT @HolzMoye: My research on use and access to innovative cancer medicines has been published. Just an example of how a middle-income count…

RT @editorjoppp: Access to innovative cancer medicines in a middle-income country - the case of Mexico https://t.co/PUDS52j0oY

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 9 additional X posts.